Beta Bionics, Inc., a leader in diabetes management solutions, announced it will release its first quarter financial results for 2025 on May 6, 2025, after market close. Management will hold a ...

Today, the Washington Post reports that a new life is within reach for the first woman with bionic arm (free registration required). Claudia Mitchell lost an arm in a motorcycle accident, but she's ...

Beta Bionics Inc. was born out of a father’s desire to improve his son’s quality of life following a diabetes diagnosis. Today, 10 years after its founding, it’s now a publicly traded company. The ...

BofA analyst Travis Steed raised the firm’s price target on Beta Bionics (BBNX) to $33 from $30 and keeps a Buy rating on the shares as the firm ...

Shares of Ekso Bionics Holdings ($EKSO) are rising in pre-market hours after it agreed to combine with Applied Digital’s ...

One day before long, we’ll be at the point where technology will be “as good as a cure” for many of us — because a truly closed-loop automated diabetes management system is getting so close we can ...

SAN RAFAEL, Calif., April 22, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today ...

Earnings call Ekso Bionics reported Q1 2025 revenue of $3.4M, down 11% YoY due to softness in enterprise health sales, but gross margin improved to 54% from 52%. Net loss narrowed to $2.9M from $3.4M.